Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v2.4.0.8
Consolidated Statements of Operations (USD $)
12 Months Ended 163 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Statements Of Operations [Abstract]      
Revenue        
Operating expenses:      
Research and development, net of reimbursements 2,666,859 3,440,485 29,087,378
General and administrative 3,919,351 4,506,232 28,424,326
Depreciation and amortization expense 1,560 581 3,264,022
Loss on disposition of equipment 4,122    554,308
Total operating expenses 6,591,892 7,947,298 61,330,034
Loss from operations (6,591,892) (7,947,298) (61,330,034)
Other income (expense):      
Interest expense (2,508) (1,099,327) (1,967,215)
Gain on extinguishment of liability       260,000
Change in fair value - derivative liabilities (4,179,392) 685,420 (3,480,006)
Total other income (expense) (4,181,900) (413,907) (5,187,221)
Net loss $ (10,773,792) $ (8,361,205) $ (66,517,255)
Net loss per common share - basic and diluted $ (0.47) $ (7.58)  
Weighted average number of common shares outstanding during the period - basic and diluted 22,752,752 1,103,521